RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
- PMID: 16076470
- DOI: 10.1016/j.atherosclerosis.2005.06.013
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes
Abstract
Previous studies demonstrated that induction of diabetes with streptozotocin (stz) accelerated atherosclerosis in hyperlipidemic apo E null (-/-) mice. Blockade of the Receptor for Advanced Glycation Endproducts (RAGE) in those animals suppressed acceleration of atherosclerotic lesion area, in a manner independent of changes in levels of glucose, insulin or lipids. In the present studies, we extended these concepts to a murine model of type 2 diabetes, and bred apo E -/- mice into the db/db background. Db/db mice are a model of obesity and insulin resistance-mediated hyperglycemia. Compared to apo E -/- m/db (non-diabetic) mice, apo E -/- db/db (diabetic) mice displayed accelerated atherosclerosis at the aortic sinus. Consistent with an important role for RAGE in this process, administration of soluble (s) RAGE, the extracellular ligand-binding domain of RAGE, resulted in significantly reduced atherosclerotic lesion area in a glycemia- and lipid-independent manner. In parallel, apo E -/- db/db mice displayed RAGE-dependent enhanced expression of Vascular Cell Adhesion Molecule-1, tissue factor and matrix metalloproteinase (MMP)-9 antigen/activity in aortae compared to non-diabetic animals. In addition, consistent with the premise that upregulation of RAGE ligands and RAGE occurs even in the non-diabetic, hyperlipidemic state, albeit to lesser degrees than in diabetes, administration of sRAGE to apo E -/- m/db mice resulted in decreased atherosclerotic lesion area at the aortic sinus. Taken together, these findings establish a new murine model for the study of atherosclerosis in type 2 diabetes and highlight important roles for RAGE in proatherogenic mechanisms in hyperglycemia triggered by insulin resistance.
Similar articles
-
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.Circulation. 2002 Nov 26;106(22):2827-35. doi: 10.1161/01.cir.0000039325.03698.36. Circulation. 2002. PMID: 12451010
-
Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.Genes Cells. 2013 Apr;18(4):302-14. doi: 10.1111/gtc.12036. Epub 2013 Feb 14. Genes Cells. 2013. PMID: 23410183
-
Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.Atherosclerosis. 2012 Apr;221(2):387-96. doi: 10.1016/j.atherosclerosis.2012.01.019. Epub 2012 Jan 13. Atherosclerosis. 2012. PMID: 22305260
-
RAGE axis: Animal models and novel insights into the vascular complications of diabetes.Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1342-9. doi: 10.1161/01.ATV.0000133191.71196.90. Epub 2004 May 20. Arterioscler Thromb Vasc Biol. 2004. PMID: 15155381 Review.
-
The AGE/RAGE axis in diabetes-accelerated atherosclerosis.Clin Exp Pharmacol Physiol. 2008 Mar;35(3):329-34. doi: 10.1111/j.1440-1681.2007.04875.x. Clin Exp Pharmacol Physiol. 2008. PMID: 18290873 Review.
Cited by
-
Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches.J Diabetes Res. 2015;2015:404085. doi: 10.1155/2015/404085. Epub 2015 Feb 15. J Diabetes Res. 2015. PMID: 25785279 Free PMC article. Review.
-
Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?Biosci Rep. 2020 Aug 28;40(8):BSR20200026. doi: 10.1042/BSR20200026. Biosci Rep. 2020. PMID: 32816039 Free PMC article. Review.
-
Advanced glycation endproducts: from precursors to RAGE: round and round we go.Amino Acids. 2012 Apr;42(4):1151-61. doi: 10.1007/s00726-010-0773-2. Epub 2010 Oct 19. Amino Acids. 2012. PMID: 20957395 Free PMC article. Review.
-
Clearance kinetics and matrix binding partners of the receptor for advanced glycation end products.PLoS One. 2014 Mar 18;9(3):e88259. doi: 10.1371/journal.pone.0088259. eCollection 2014. PLoS One. 2014. PMID: 24642901 Free PMC article.
-
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.Mol Metab. 2013 Dec 7;3(2):94-108. doi: 10.1016/j.molmet.2013.11.006. eCollection 2014 Apr. Mol Metab. 2013. PMID: 24634815 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous